West Pharmaceutical Services Inc Stock News

WST earnings call for the period ending December 31, 2021.

West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q4 2021 Results - Earnings Call Transcript

West Pharmaceutical Services Inc''s (NYSE: WST ) Q4 net sales increased 26% Y/Y to $730.8 million , beating the consensus of $710.20 million. Organic sales growth was 28.3%. Q4 FY21 EPS reached $2.04 from $1.34 a year ago, surpassing the consensus of $1.91. Gross profit increased from 36.4% to 41.1%. Adjusted operating profit margin reached … Full story available on Benzinga.com

West Pharmaceutical press release (WST): Q4 Non-GAAP EPS of $2.04 beats by $0.12.Revenue of $730.8M (+26.0% Y/Y) beats by $20.6M.Company is introducing full-year 2022 financial…

West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.

West Pharmaceutical (WST) delivered earnings and revenue surprises of 6.25% and 3.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

West Pharmaceutical (NYSE:WST) is scheduled to announce Q4 earnings on Thursday, Feb. 17, before market open.The consensus EPS estimate is $1.92 (+43.3% Y/Y)

West Pharmaceutical's (WST) fourth-quarter results are likely to reflect strength in the Proprietary Products business.

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

In the latest trading session, West Pharmaceutical Services (WST) closed at $400.69, marking a -0.01% move from the previous day.

The womens Hundred cricket tournament and Womens Super League soccer brought in nearly 11 million new viewers as womens sport attracted record viewing figures in Britain in 2021, the Womens Sport Trust (WST) said on Tuesday. The trusts Visibility Uncovered study found that almost 33 million people tuned in to womens sport last year, with []

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will relea

Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The global sterile medical packaging market size is expected to reach USD 68.49 billion by 2028, exhibiting a CAGR of 8.1% during the forecast period. The growing cognizance about the advantageous properties of sterile medical packaging such as tear resistance, durability, breathability, and the superior microbial barrier will promote the growth of the market during the forecast period. The market size stood at USD 35.74 Billion in 2020. The escalating requirements for sterile medical packaging in numerous applications, involving in-vitro diagnostic products and surgical & medical instruments will have a positive impact on the market in the forthcoming years. The Report Lists the Key Companies in the Sterile Medical Packaging Market: Amcor Plc (Switzerland) Placon (U.S.) DuPont (U.S.) Steripack Ltd. (Ireland) Wipak Group (Finland) Nelipak Healthcare (U.S.) Tekni-Plex(U.S.) Sonoco (U.S.) BillerudKorsnäs AB (Sweden) ProAmpac (U.S.) West Pharmaceutical Services, Inc. (U.S.) Riverside Medical Packaging Company Ltd (UK) Oliver Healthcare Packaging (U.S.) GS Medical Packaging (Canada) Orchid (U.S.) Techinipaq Inc. (U.S.) Others Get a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/sterile-medical-packaging-market-102798 Market Driver : Growing Hygiene and Sterility in Medical Equipment to Stimulate Growth The increasing prevalence of infectious and communicable diseases and viruses such as COVID-19, flu, tuberculosis, and SARS has led to improved hygiene in medical devices intending to prevent any contamination or spread of disease in patients.

West Pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Products business. However, forex woes persist.